Page last updated: 2024-09-04

pentacyanoferrate (ii) and Lung Diseases

pentacyanoferrate (ii) has been researched along with Lung Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Basso, LA; Calixto, JB; Campos, MM; de França Lopes, LG; Dos Santos Junior, A; Dos Santos, AJ; Rodrigues-Junior, VS; Santos, DS; Schneider, CZ; Sousa, EH; Souto, AA	1

Other Studies

1 other study(ies) available for pentacyanoferrate (ii) and Lung Diseases

Article	Year
Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection. International journal of antimicrobial agents, 2012, Volume: 40, Issue:2 Topics: Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Drug Evaluation, Preclinical; Ferrous Compounds; Isoniazid; Lung; Lung Diseases; Male; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Tuberculosis	2012

Article

Year

Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection.

International journal of antimicrobial agents, 2012, Volume: 40, Issue:2

Topics: Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Drug Evaluation, Preclinical; Ferrous Compounds; Isoniazid; Lung; Lung Diseases; Male; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Tuberculosis

2012